Corporate Banner
Satellite Banner
Automation & Microfluidics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Roche and Agilent to Provide Continued Service and Support to Roche NimbleGen Microarray Customers

Published: Wednesday, November 07, 2012
Last Updated: Wednesday, November 07, 2012
Bookmark and Share
Transition of services beginning immediately.

Roche and Agilent Technologies, Inc. announced the signing of an exclusive agreement to provide continued service to NimbleGen microarray customers as Roche phases-out its NimbleGen array production and services. Researchers using NimbleGen microarrays for all applications, including comparative genomic hybridization, chromatin immunoprecipitation-on-chip, DNA methylation, and gene expression can transition to Agilent arrays, effective immediately, with minimal disruption. The similarities of the technologies and products from both companies provide an optimal transition path and the ability to run Agilent microarrays on the NimbleGen MS 200 Microarray Scanner.

“This global collaboration provides our customers with a confident and straightforward solution to move from NimbleGen to Agilent microarrays,” said Dan Zabrowski, Head of Roche Applied Science. “With Agilent as a leading global supplier of microarray technology, we are convinced researchers will be provided with the highest compatibility to NimbleGen products and services, and believe that they will continue to receive the exceptional service and support they have come to expect.”

“We are working closely with Roche to help customers make the transition to Agilent microarray products,” said Robert Schueren, vice president and general manager of Agilent’s Genomics Systems Division. “Our field service personnel are working directly with individual researchers to help convert their NimbleGen designs, and they will continue to provide enhanced service and support throughout the transition period and beyond. Additionally, Agilent is also enabling customers to read their arrays on NimbleGen scanners, eliminating the need to invest in capital equipment.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Hamilton Introduces Automated DNA Sample Enrichment Solution
System uses Roche 454 REM e liquid handling system to replace hours of manual work.
Tuesday, January 31, 2012
Roche and Labcyte Integrate Echo and LightCycler Systems to Increase Performance of qPCR-based RNA/DNA Analyses
Companies cooperate around high-speed, miniaturized quantitative PCR (qPCR) to monitor the expression of tens to thousands of genes for therapeutic research.
Wednesday, December 07, 2011
Canterbury Health Laboratories (NZ) Adopts NimbleGen Microarray Cytogenetics Solution for Mental Retardation Research
Roche NimbleGen have announced that one of New Zealand’s largest medical laboratories has adopted the NimbleGen CGX Cytogenetics Microarray Solution.
Monday, November 15, 2010
DNA Electronics Partners with Roche to Develop Semiconductor Based Sequencing System
Collaboration to focus on development of a low-cost, high-throughput, long read, high density DNA sequencing system.
Tuesday, November 02, 2010
Gene Biodesign Certified to Provide NimbleGen Array Services in Taiwan
Gene Biodesign has been certified to process customer samples in northern Taipei county for NimbleGen array applications.
Friday, October 15, 2010
Macrogen, Inc. Certified as NimbleGen Array Service Provider for Korea
Macrogen has been certified to process customer samples for NimbleGen CGH/CNV services in their lab in Seoul.
Wednesday, July 14, 2010
Roche NimbleGen Commits to GMP and FDA Submission for Microarrays
Roche NimbleGen announces a company-wide initiative to implement Good Manufacturing Processes for its suite of DNA microarrays.
Thursday, April 08, 2010
Roche Collaborates with Merck on Developmental Test for Cancer-Related Gene Mutation
Investigational AmpliChip p53 test designed to screen for genetic mutation tied to therapeutic resistance in cancer patients.
Friday, February 19, 2010
CapitalBio Corporation Certified to Provide NimbleGen Array Services in China
CapitalBio becomes the first NimbleGen CSP in Asia to implement the MS 200 Microarray Scanner.
Monday, February 15, 2010
imaGenes GmbH Joins Roche NimbleGen’s Certified Service Provider Program for ChIP-chip Analysis
imaGenes achieves status as a CSP of NimbleGen microarrays for Chromatin Immunoprecipitation.
Wednesday, December 16, 2009
Roche and High Throughput Genomics Partner for Advanced Gene Expression Analysis Solution
Roche NimbleGen will provide HTG with high density, multiplex DNA microarray slides for advanced gene expression analysis.
Monday, November 09, 2009
Roche Applied Science Announces CGX Arrays Designed by Signature Genomics for Microarray-based Cytogenetic Analysis
The CGX arrays are designed by Signature Genomic Laboratories to provide high-resolution, genome-wide analysis of chromosomal abnormalities.
Monday, November 09, 2009
Roche and High Throughput Genomics Partner for Advanced Gene Expression Analysis Solution
Roche NimbleGen and High Throughput Genomics, Inc. (HTG), provider of the quantitative Nuclease Protection Assay (qNPA), have entered into a supply agreement. Under the agreement, Roche NimbleGen will provide HTG with high density, multiplex DNA microarray slides for advanced gene expression analysis.
Wednesday, October 21, 2009
Roche NimbleGen CGH Microarrays Enable the First Maps of Genome-Wide DNA CNV in Dogs
Studies reveal that the extent of CNVs in the dog genome and their association with known and candidate disease genes is similar to mice and humans.
Friday, May 08, 2009
Roche NimbleGen Microarrays Selected for the Neuromuscular Disorder -Chip Consortium
The NMD-Chip Consortium selects Roche NimbleGen microarrays to accelerate and simplify genetic research of neuromuscular disorders.
Friday, February 27, 2009
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Biosensor Detects Molecules Linked to Cancer, Alzheimer's and Parkinson's
Novel biosensor has been proven capable of detecting molecules associated with neurodegenerative diseases and some types of cancer.
New Device Could Improve Cancer Detection
UBC researchers develop a microfluidic device to capture circulating tumor cells.
Gut Model HuMiX Works Like the Real Thing
Developed by scientists at the Luxembourg Centre for Systems Biology, the “Human Microbial Cross-talk” model is representative of the actual conditions and processes that occur within our intestines.
'Kidney on a Chip' Facilitates Safer Drug Dosing
University of Michigan researchers have used a "kidney on a chip" device to mimic the flow of medication through human kidneys and measure its effect on kidney cells.
AACR 2016: Cancer Immunotherapy and Beyond
At this year's meeting there was a palpable buzz around subjects ranging from microbiomics to the tumor microenvironment and cancer vaccines, big data to in vitro and in vivo modeling and drug delivery (to name just a few).
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Lab-on-a-Chip for Detecting Glucose
By integrating microfluidic chips with fiber optic biosensors, researchers in China are creating ultrasensitive lab-on-a-chip devices to detect glucose levels.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Soy Shows Promise as Natural Anti-Microbial Agent
Researchers from University of Guelph show that soy isoflavones and peptides could be used to reduce microbial contamination of food.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!